Javascript must be enabled to continue!
ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
View through CrossRef
Abstract
Introduction
Myxedema coma, a medical emergency, refers to severe hypothyroidism which can be precipitated by several factors including acute infection, myocardial infarction, and hypothermia. Rarely, patients may present with myxedema psychosis which manifests as suicidal ideations, hallucinations and or delusions.
Case Presentation
A 60-year-old woman with a history of hypertension, hypothyroidism, anxiety disorder and heroin abuse on methadone 50 mg every day presented to the hospital with acute onset of altered mental status. Per the patient, she called 911 for "cardiac arrest and talking about dead bodies". Upon presentation, the patient was hypertensive, 184/124mmHg. Physical exam was notable for active hallucinations. She was alert and oriented to person and place, with an unsteady gait. Laboratory examination was remarkable for hyponatremia 131 mmol/L (137-147 mmol/L). She received workup for acute encephalopathy and ED physicians determined that if the workup was negative, she should be evaluated by Psychiatry. Infectious processes and drug intoxication/overdose were ruled out. Psychiatry determined that the patient's psychosis was due to an organic etiology. Follow-up laboratory showed TSH 155 ulU/mL (0.350-4.80 ulU/mL), free thyroxine 4 < 0.1 ng/dL (0.90-1.8 ng/dL) and thyroid peroxidase antibody 460 IU/ml (<34.9). While in the ICU, she became bradycardic, heart rate 25 bpm, and hypoxic, O2 saturation ∼ 75%. She was placed on nasal cannula with improved oxygenation. Later she experienced two seizures lasting approximately 1 minute. The patient received stress dose steroids intravenously every 8 hours and levothyroxine intravenously. Adrenal insufficiency workup was within normal limits. On hospital day 3, her mental status improved and she was transitioned to oral levothyroxine. The patient was transferred to the medical floor for further care. Upon questioning, she reported she stopped taking her levothyroxine for approximately 6 months. Her delusions decreased and later resolved on hospital day 10. She was discharged home with 100 mcg oral levothyroxine and outpatient follow-up with Endocrinology.
Conclusion
Our patient presented with a rare manifestation of severe hypothyroidism, myxedema madness. The relationship between psychosis and thyroid dysfunction has long been documented. In the same period, there has only been a few reported cases of myxedema madness in literature, generally reported in Psychiatric journals. This is surprising, given that these are endocrinological emergencies. Importantly, patients with an acute presentation of psychosis, should be tested for thyroid abnormalities, as this is reversible. In our patient's case, she had no previous documented psychiatric history. It is reasonable therefore to conclude that, herlikely myxedema madness resulted from prolonged thyroid replacement non-compliance.
Presentation: No date and time listed
Title: ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
Description:
Abstract
Introduction
Myxedema coma, a medical emergency, refers to severe hypothyroidism which can be precipitated by several factors including acute infection, myocardial infarction, and hypothermia.
Rarely, patients may present with myxedema psychosis which manifests as suicidal ideations, hallucinations and or delusions.
Case Presentation
A 60-year-old woman with a history of hypertension, hypothyroidism, anxiety disorder and heroin abuse on methadone 50 mg every day presented to the hospital with acute onset of altered mental status.
Per the patient, she called 911 for "cardiac arrest and talking about dead bodies".
Upon presentation, the patient was hypertensive, 184/124mmHg.
Physical exam was notable for active hallucinations.
She was alert and oriented to person and place, with an unsteady gait.
Laboratory examination was remarkable for hyponatremia 131 mmol/L (137-147 mmol/L).
She received workup for acute encephalopathy and ED physicians determined that if the workup was negative, she should be evaluated by Psychiatry.
Infectious processes and drug intoxication/overdose were ruled out.
Psychiatry determined that the patient's psychosis was due to an organic etiology.
Follow-up laboratory showed TSH 155 ulU/mL (0.
350-4.
80 ulU/mL), free thyroxine 4 < 0.
1 ng/dL (0.
90-1.
8 ng/dL) and thyroid peroxidase antibody 460 IU/ml (<34.
9).
While in the ICU, she became bradycardic, heart rate 25 bpm, and hypoxic, O2 saturation ∼ 75%.
She was placed on nasal cannula with improved oxygenation.
Later she experienced two seizures lasting approximately 1 minute.
The patient received stress dose steroids intravenously every 8 hours and levothyroxine intravenously.
Adrenal insufficiency workup was within normal limits.
On hospital day 3, her mental status improved and she was transitioned to oral levothyroxine.
The patient was transferred to the medical floor for further care.
Upon questioning, she reported she stopped taking her levothyroxine for approximately 6 months.
Her delusions decreased and later resolved on hospital day 10.
She was discharged home with 100 mcg oral levothyroxine and outpatient follow-up with Endocrinology.
Conclusion
Our patient presented with a rare manifestation of severe hypothyroidism, myxedema madness.
The relationship between psychosis and thyroid dysfunction has long been documented.
In the same period, there has only been a few reported cases of myxedema madness in literature, generally reported in Psychiatric journals.
This is surprising, given that these are endocrinological emergencies.
Importantly, patients with an acute presentation of psychosis, should be tested for thyroid abnormalities, as this is reversible.
In our patient's case, she had no previous documented psychiatric history.
It is reasonable therefore to conclude that, herlikely myxedema madness resulted from prolonged thyroid replacement non-compliance.
Presentation: No date and time listed.
Related Results
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
Abstract
Myxedema coma is a medical emergency with a mortality rate of 30–50%. It is a commonly missed diagnosis and can lead to multiple cardiovascular complication...
Amiodarone induced myxedema coma presenting with cardiogenic shock and junctional rhythm
Amiodarone induced myxedema coma presenting with cardiogenic shock and junctional rhythm
We describe the case of an elderly female, with no prior history of thyroid dysfunction, who presented with facial swelling and worsening fatigue. She was found to have myxedema co...
Amiodarone Induced Myxedema Coma: A Systematic Review of Case Reports
Amiodarone Induced Myxedema Coma: A Systematic Review of Case Reports
AbstractObjective The current systematic review examined whether elderly patients who received amiodarone were at risk for developing myxedema coma. Methods The Cochrane guidelines...
Madness in music
Madness in music
Name: May Kristin Svanholm Hegvold
Main Subject: Early Music Singing
Research Supervisor: Inês de Avena Braga
Title of Research: Madness in music
Research Question: How can one...
Short-term Withdrawal of Levothyroxine, Induced Increase of Thyroid-stimulating Hormone and an Increase Ratio of Triiodothyronine to Thyroxine
Short-term Withdrawal of Levothyroxine, Induced Increase of Thyroid-stimulating Hormone and an Increase Ratio of Triiodothyronine to Thyroxine
Objective:Treatment with levothyroxine in primary hypothyroid patients does not always provide complete regression of associated symptoms despite normalised TSH levels. Several sou...
Severe hypothyroidism approaching myxedema coma: A case report
Severe hypothyroidism approaching myxedema coma: A case report
Severe hypothyroidism is not a presentation that is encountered daily in the hospital setting. Patients' major complaints are generally seen in common diseases or significant past ...
ODP502 Nodular Pretibial Myxedema without Graves’ Orbitopathy: A Case Report
ODP502 Nodular Pretibial Myxedema without Graves’ Orbitopathy: A Case Report
Abstract
Background
Nodular myxedema is an uncommon skin manifestation of autoimmune thyroid disease. Almost always associated w...
Detection and Characterization of an Unknown Impurity in Levothyroxine Sodium Tablets by UHPLC, LC/MS, MS/MS and MS/MS/MS
Detection and Characterization of an Unknown Impurity in Levothyroxine Sodium Tablets by UHPLC, LC/MS, MS/MS and MS/MS/MS
Impurities in the active ingredient of a drug are very important for the quality and reliability of the finished product. Therefore, the identification of these impurities constitu...

